StockVS

NASDAQ · USD

Alpha Tau Medical Ltd. (DRTSW) Stock Analysis

Alpha Tau Medical Ltd. (DRTSW) is a stock listed on NASDAQ and quoted in US Dollar.

DRTSW

$4.17

+$0.25 (+6.38%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on Alpha Tau Medical Ltd. (DRTS) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View DRTS →

Price History

Hover for the daily close. The dotted line marks the period open.

DRTSW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.33
Previous Close
$3.92
Day's Range
3.86–4.28
52-Week Range
3.86–4.28
Volume
46.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.21

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

DRTSW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+1163.64%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Visit website →